Stephens Resumes Myriad Genetics (MYGN) at Overweight

May 9, 2013 7:53 AM

Stephens resumed coverage on Myriad Genetics (NASDAQ: MYGN) with an Overweight rating ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found